STALLERGENES, an major playerin desensitisation therapy:

• Nearly 1 million preparations are supplied by STALLERGENES in the world each year

• Nearly 500 000 patients were treated by STALLERGENES in 2006

• Over 600 men and women are employed by STALLERGENES throughout the world.

• STALLERGENES devotes 17% of its 2007 sales to the research and development for better therapeutic solutions.  

• STALLERGENES has initiated and conducted nearly 30 controlled clinical studies since 2000, including nearly 2700 patients in total.

Key Figures 2006

• Consolidated Sales  

• Breakdown of Sales 

• Margin before R&D  

• EBIT and R&D
  

• Net Profit
  

• Net financial liabilities and EBITDA  

• ROE : Return on Equity  

• Workforce as at 31.12 

Download Key figures 2006